company background image
MDVL

MedAvail HoldingsNasdaqCM:MDVL Stock Report

Market Cap

US$84.5m

7D

-7.9%

1Y

n/a

Updated

22 Oct, 2021

Data

Company Financials +
MDVL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

MDVL Overview

MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology.

Price History & Performance

Summary of all time highs, changes and price drops for MedAvail Holdings
Historical stock prices
Current Share PriceUS$2.58
52 Week HighUS$2.52
52 Week LowUS$20.79
Beta0
1 Month Change-19.12%
3 Month Change-72.23%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-71.33%

Recent News & Updates

Aug 17
Some Analysts Just Cut Their MedAvail Holdings, Inc (NASDAQ:MDVL) Estimates

Some Analysts Just Cut Their MedAvail Holdings, Inc (NASDAQ:MDVL) Estimates

The latest analyst coverage could presage a bad day for MedAvail Holdings, Inc ( NASDAQ:MDVL ), with the analysts...

May 24
Calculating The Intrinsic Value Of MedAvail Holdings, Inc (NASDAQ:MDVL)

Calculating The Intrinsic Value Of MedAvail Holdings, Inc (NASDAQ:MDVL)

Does the May share price for MedAvail Holdings, Inc ( NASDAQ:MDVL ) reflect what it's really worth? Today, we will...

Shareholder Returns

MDVLUS Consumer RetailingUS Market
7D-7.9%4.6%1.7%
1Yn/a13.9%30.3%

Return vs Industry: Insufficient data to determine how MDVL performed against the US Consumer Retailing industry.

Return vs Market: Insufficient data to determine how MDVL performed against the US Market.

Price Volatility

Is MDVL's price volatile compared to industry and market?
MDVL volatility
MDVL Beta0
Industry Beta0.62
Market Beta1

Stable Share Price: MDVL is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 18% a week.

Volatility Over Time: MDVL's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a224Ed Kilroyhttps://www.medavail.com

MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery.

MedAvail Holdings Fundamentals Summary

How do MedAvail Holdings's earnings and revenue compare to its market cap?
MDVL fundamental statistics
Market CapUS$84.49m
Earnings (TTM)-US$34.50m
Revenue (TTM)US$19.30m

4.4x

P/S Ratio

-2.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MDVL income statement (TTM)
RevenueUS$19.30m
Cost of RevenueUS$14.07m
Gross ProfitUS$5.23m
ExpensesUS$39.73m
Earnings-US$34.50m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-1.05
Gross Margin27.10%
Net Profit Margin-178.74%
Debt/Equity Ratio24.7%

How did MDVL perform over the long term?

See historical performance and comparison

Valuation

Is MedAvail Holdings undervalued compared to its fair value and its price relative to the market?

2.01x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MDVL's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate MDVL's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: MDVL is unprofitable, so we can't compare its PE Ratio to the US Consumer Retailing industry average.

PE vs Market: MDVL is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MDVL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MDVL is good value based on its PB Ratio (2x) compared to the US Consumer Retailing industry average (2.3x).


Future Growth

How is MedAvail Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

8.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MDVL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MDVL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MDVL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MDVL's revenue (50.2% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: MDVL's revenue (50.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MDVL's Return on Equity is forecast to be high in 3 years time


Past Performance

How has MedAvail Holdings performed over the past 5 years?

-44.9%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: MDVL is currently unprofitable.

Growing Profit Margin: MDVL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MDVL's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare MDVL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDVL is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (25%).


Return on Equity

High ROE: MDVL has a negative Return on Equity (-81.95%), as it is currently unprofitable.


Financial Health

How is MedAvail Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: MDVL's short term assets ($54.1M) exceed its short term liabilities ($8.9M).

Long Term Liabilities: MDVL's short term assets ($54.1M) exceed its long term liabilities ($10.2M).


Debt to Equity History and Analysis

Debt Level: MDVL's debt to equity ratio (24.7%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if MDVL's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MDVL has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MDVL has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 38.4% each year.


Dividend

What is MedAvail Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MDVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDVL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MDVL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDVL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MDVL's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.8yrs

Average management tenure


CEO

Ed Kilroy (61 yo)

0.92

Tenure

US$440,771

Compensation

Mr. Edwin J. Kilroy, also known as Ed, is President, Chief Executive Officer and Director of MedAvail Holdings, Inc since November 16, 2020. He has served as Private MedAvail President and Chief Executive...


CEO Compensation Analysis

Compensation vs Market: Ed's total compensation ($USD440.77K) is about average for companies of similar size in the US market ($USD545.51K).

Compensation vs Earnings: Ed's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: MDVL's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

Experienced Board: MDVL's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: MDVL only recently listed within the past 12 months.


Top Shareholders

Company Information

MedAvail Holdings, Inc's employee growth, exchange listings and data sources


Key Information

  • Name: MedAvail Holdings, Inc
  • Ticker: MDVL
  • Exchange: NasdaqCM
  • Founded: NaN
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: US$84.486m
  • Shares outstanding: 32.75m
  • Website: https://www.medavail.com

Number of Employees


Location

  • MedAvail Holdings, Inc
  • 6665 Millcreek Drive
  • Unit 1
  • Mississauga
  • Ontario
  • L5N 5M4
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/22 23:08
End of Day Share Price2021/10/22 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.